AstraZeneca ordered to pay $108m to Pfizer in US cancer drug patent trial
The jury found that Tagrisso violated two patents related to methods for cancer treatment with Nerlynx, a drug…
We use them to give you the best experience. If you continue using our website, we'll assume that you are happy to receive all cookies on this website.
ContinueLearn More X
20 May 24
The jury found that Tagrisso violated two patents related to methods for cancer treatment with Nerlynx, a drug…
20 May 24
The approval was based on the positive results from Phase 3 ATTACK trial in which Xacduro proved its…
20 May 24
Funding of £85 million will be announced at a global event to support the international community in tackling…
17 May 24
The acquisition includes PX128, a bispecific antibody that targets IL-13 and TSLP, and PX130, which is focused on…
16 May 24
The approval is based on results from open-label, global, multicentre, Phase 2, single-arm TRANSCEND FL study in which…
15 May 24
DoH and GSK will work together to maximise the strategic and healthcare impacts of the newly established vaccine…
15 May 24
China’s NMPA approved Nefecon in late 2023 for the treatment of primary IgAN in adults who are at…
15 May 24
GenoBlend is made from premium ingredients, including organic pea protein, organic brown rice protein, organic citrus fibre, and…
15 May 24
Upstaza is a one-time gene replacement therapy intended for patients aged 18 months and older who have a…
15 May 24
The study brings together Verismo's proprietary SynKIR platform and novel CD19 binder to treat CAR-naïve and post-CAR relapsed…